These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 27915006)
1. Predicting optimal wet granulation parameters for extrusion-spheronisation of pharmaceutical pellets using a mixer torque rheometer. Kuhs M; Moore J; Kollamaram G; Walker G; Croker D Int J Pharm; 2017 Jan; 517(1-2):19-24. PubMed ID: 27915006 [TBL] [Abstract][Full Text] [Related]
2. Development of starch-based pellets via extrusion/spheronisation. Dukić A; Mens R; Adriaensens P; Foreman P; Gelan J; Remon JP; Vervaet C Eur J Pharm Biopharm; 2007 Apr; 66(1):83-94. PubMed ID: 17045467 [TBL] [Abstract][Full Text] [Related]
3. Faster to First-time-in-Human: Prediction of the liquid solid ratio for continuous wet granulation. Junnila A; Wikström H; Megarry A; Gholami A; Papathanasiou F; Blomberg A; Ketolainen J; Tajarobi P Eur J Pharm Sci; 2022 May; 172():106151. PubMed ID: 35217210 [TBL] [Abstract][Full Text] [Related]
4. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation. Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353 [TBL] [Abstract][Full Text] [Related]
5. Production of pellets via extrusion-spheronisation without the incorporation of microcrystalline cellulose: a critical review. Dukić-Ott A; Thommes M; Remon JP; Kleinebudde P; Vervaet C Eur J Pharm Biopharm; 2009 Jan; 71(1):38-46. PubMed ID: 18771727 [TBL] [Abstract][Full Text] [Related]
6. Formulation and evaluation of mefenamic acid sustained release matrix pellets. Ibrahim MA Acta Pharm; 2013 Mar; 63(1):85-98. PubMed ID: 23482315 [TBL] [Abstract][Full Text] [Related]
7. The evaluation of formulations for the preparation of pellets with high drug loading by extrusion/spheronization. Podczeck F; Knight P Pharm Dev Technol; 2006; 11(3):263-74. PubMed ID: 16895837 [TBL] [Abstract][Full Text] [Related]
8. Development of new laboratory tools for assessment of granulation behavior during bulk active pharmaceutical ingredient drying. Zhang S; Lamberto DJ J Pharm Sci; 2014 Jan; 103(1):152-60. PubMed ID: 24338750 [TBL] [Abstract][Full Text] [Related]
9. Immediate release of poorly soluble drugs from starch-based pellets prepared via extrusion/spheronisation. Dukić-Ott A; Remon JP; Foreman P; Vervaet C Eur J Pharm Biopharm; 2007 Nov; 67(3):715-24. PubMed ID: 17537625 [TBL] [Abstract][Full Text] [Related]
10. [Wetting agent dosage screening for traditional Chinese medicine pellet based on torque rheological property]. Li X; Hong YL; Xian JC; Feng Y; Zheng YP; Chu SC Zhongguo Zhong Yao Za Zhi; 2017 Sep; 42(17):3341-3349. PubMed ID: 29192444 [TBL] [Abstract][Full Text] [Related]
11. Physicochemical properties of granulating liquids and their influence on microcrystalline cellulose pellets obtained by extrusion-spheronisation technology. Dreu R; Sirca J; Pintye-Hodi K; Burjan T; Planinsek O; Srcic S Int J Pharm; 2005 Mar; 291(1-2):99-111. PubMed ID: 15707736 [TBL] [Abstract][Full Text] [Related]
12. The use of partially hydrolysed polyvinyl alcohol for the production of high drug-loaded sustained release pellets via extrusion-spheronisation and coating: In vitro and in vivo evaluation. Verstraete G; De Jaeghere W; Vercruysse J; Grymonpré W; Vanhoorne V; Stauffer F; De Beer T; Bezuijen A; Remon JP; Vervaet C Int J Pharm; 2017 Jan; 517(1-2):88-95. PubMed ID: 27919698 [TBL] [Abstract][Full Text] [Related]
13. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. I. Influence of type and fraction of filler. Thommes M; Kleinebudde P Eur J Pharm Biopharm; 2006 May; 63(1):59-67. PubMed ID: 16326085 [TBL] [Abstract][Full Text] [Related]
15. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. II. Influence of drug and filler type. Thommes M; Kleinebudde P Eur J Pharm Biopharm; 2006 May; 63(1):68-75. PubMed ID: 16325384 [TBL] [Abstract][Full Text] [Related]
16. The use of mixer torque rheometry to study the effect of formulation variables on the properties of wet granulations. Hariharan M; Mehdizadeh E Drug Dev Ind Pharm; 2002 Mar; 28(3):253-63. PubMed ID: 12026218 [TBL] [Abstract][Full Text] [Related]
17. Development of a controlled release formulation by continuous twin screw granulation: Influence of process and formulation parameters. Vanhoorne V; Vanbillemont B; Vercruysse J; De Leersnyder F; Gomes P; Beer TD; Remon JP; Vervaet C Int J Pharm; 2016 May; 505(1-2):61-8. PubMed ID: 27041123 [TBL] [Abstract][Full Text] [Related]
18. Utilizing mixer torque rheometer in the prediction of optimal wet massing parameters for pellet formulation by extrusion/spheronization. Ibrahim MA; Zayed GM; Alsharif FM; Abdelhafez WA Saudi Pharm J; 2019 Feb; 27(2):182-190. PubMed ID: 30766428 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of diclofenac sodium sustained release matrix pellets: impact of polyethylene glycols molecular weight. Ibrahim A; Shazly A Acta Pol Pharm; 2014; 71(5):821-31. PubMed ID: 25362811 [TBL] [Abstract][Full Text] [Related]
20. Texture analysis as a tool to study the kinetics of wet agglomeration processes. Nalesso S; Codemo C; Franceschinis E; Realdon N; Artoni R; Santomaso AC Int J Pharm; 2015 May; 485(1-2):61-9. PubMed ID: 25746734 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]